Blog

The Role of Enrolment in Clinical Trials

23/02/2024

Clinical trials are at the heart of advancements in medicine and healthcare. They are instrumental in developing new treatments, improving existing ones, and enhancing patient care protocols. However, the success of these trials largely depends on one key aspect: patient enrolment. What is patient enrolment in clinical trials? Enrolment in clinical trials refers to the […]

Read More

How to Reduce Clinical Trial Site Burden

23/02/2024

A major component that impacts the success of a clinical trial is patient participation. It can be difficult enough to recruit patients for clinical trials, but even following recruitment, participant retention is a whole other challenge. At site level, there are several factors that can make it difficult for participants to stay engaged with the […]

Read More

The Key to Effective Site Management in Clinical Research

23/02/2024

Conducting a successful clinical research study requires effective site management, which involves managing all aspects of the study at the research site. In this blog, we will explore the essential components of effective site management, including participant recruitment and retention, data management, site monitoring, and regulatory compliance. What is site management in clinical research? Site […]

Read More

What are Early Phase Clinical Trials?

23/02/2024

Early phase clinical trials, also known as phase I trials, are the first stage of testing a new medical treatment, drug, or device in human subjects. The focus of these trials in clinical development is to determine the safety and tolerability of the treatment, as well as to identify any potential side effects. You might […]

Read More

How can AI improve patient outcomes in clinical trials?

20/02/2024

Welcome back to our blog series where we share some of the highlights and key takeaways from our fireside chat with CEO of Simbec-Orion, Fabrice Chartier, and CEO of biotx.ai, Joern Klinger. Our last blog post covered whether AI can help with achieving orphan drug status, recent trends in clinical trial design, how AI can […]

Read More

Can AI help with achieving orphan drug status?

13/02/2024

Welcome back to our blog series where we share some of the highlights and key takeaways from our fireside chat with CEO of Simbec-Orion, Fabrice Chartier, and CEO of biotx.ai, Joern Klinger. Our last blog post covered how AI can demonstrate the potential of the pipeline to investors and how AI could disrupt clinical development […]

Read More

How does AI-enabled causal modelling support discussions with potential investors?

06/02/2024

Welcome back to our blog series where we share some of the highlights and key takeaways from our fireside chat with CEO of Simbec-Orion, Fabrice Chartier, and CEO of biotx.ai, Joern Klinger. Our last blog post covered what AI-enabled causal modelling is, how it is different from other models, and where you might want to […]

Read More

Got a question?
Get in Touch or Submit an RFI/RFP

Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Name(Required)
Opt In Emails